These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14202589)

  • 21. AUTOLOGOUS MARROW IN TREATMENT OF NITROGEN MUSTARD-INDUCED MARROW DEPRESSION.
    KAISER GA; HERTER FP; MARKOWITZ AM; EVANS S
    Surgery; 1963 Aug; 54():329-32. PubMed ID: 14054722
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitrogen-mustard therapy combined with autologous marrow infusion.
    CLIFFORD P; CLIFT RA; DUFF JK
    Lancet; 1961 Apr; 1(7179):687-90. PubMed ID: 13694099
    [No Abstract]   [Full Text] [Related]  

  • 23. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE.
    ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N
    Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TREATMENT OF CANCER OF THE HEAD AND NECK BY CHEMOTHERAPY.
    BEAHRS OH; CALDAROLA VT; HARRISON EG
    JAMA; 1964 Sep; 189():765. PubMed ID: 14174055
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of pentoxyl on the lipids of the bone marrow of rabbits in experimental leukopenia].
    MOROZOVA EN
    Biull Eksp Biol Med; 1961 Feb; 51():54-9. PubMed ID: 13772779
    [No Abstract]   [Full Text] [Related]  

  • 26. THERAPEUTIC EFFECT OF ANTICANCER DRUGS ON SKIN CANCER.
    HIGUCHI K; UEMATSU K
    Kyushu J Med Sci; 1963 Oct; 14():203-9. PubMed ID: 14104458
    [No Abstract]   [Full Text] [Related]  

  • 27. [REGIONAL CHEMOTHERAPY OF HEAD AND NECK CANCER (APROPOS OF 24 INFUSIONS AND 19 REGIONAL ARTERIAL PERFUSIONS)].
    APPAIX A; DEVIN R; PECH A; GARCIN M; SPITALIER JM
    Presse Med (1893); 1963 Sep; 71():1803-6. PubMed ID: 14090984
    [No Abstract]   [Full Text] [Related]  

  • 28. THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
    JOHNSTON ID
    Ulster Med J; 1963 Dec; 32(2):151-9. PubMed ID: 14105942
    [No Abstract]   [Full Text] [Related]  

  • 29. URACIL MUSTARY THERAPY IN METASTATIC WILMS'S TUMOR.
    VIETTI TJ; BERRY DH; FERNBACH DJ; LUSHER J; SUTOW WW
    Am J Dis Child; 1964 Nov; 108():530-2. PubMed ID: 14209688
    [No Abstract]   [Full Text] [Related]  

  • 30. CLOSED PELVIC PERFUSION: ISOLATION PERFUSION OF THE PELVIS WITHOUT CELIOTOMY.
    MARTIN DS; WHITE HM; HOBBS J; KURZWEG FT; HUDSON PJ
    Surgery; 1964 Dec; 56():1056-63. PubMed ID: 14238359
    [No Abstract]   [Full Text] [Related]  

  • 31. PROTECTION STUDIES WITH SODIUM THIOSULFATE AGAINST METHYL BIS (BETA-CHLOROETHYL)AMINE HYDROCHLORIDE (HN2) AND ITS ETHYLENIMONIUM DERIVATIVE.
    BONADONNA G; KARNOFSKY DA
    Clin Pharmacol Ther; 1965; 6():50-64. PubMed ID: 14253284
    [No Abstract]   [Full Text] [Related]  

  • 32. CHLORAMBUCIL-PREDNISOLONE THERAPY FOR DISSEMINATED BREAST CARCINOMA.
    FRECKMAN HA; FRY HL; MENDEZ FL; MAURER ER
    JAMA; 1964 Jul; 189():23-6. PubMed ID: 14149018
    [No Abstract]   [Full Text] [Related]  

  • 33. REDUCTION OF THE TOXICITY OF 'RADIOMIMETIC' ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. 3. THE MECHANISM OF THE PROTECTIVE ACTION OF THIOSULPHATE.
    CONNORS TA; JENEY A; JONES M
    Biochem Pharmacol; 1964 Dec; 13():1545-50. PubMed ID: 14248383
    [No Abstract]   [Full Text] [Related]  

  • 34. HAEMODYNAMIC EFFECTS OF OCCLUSION OF ABDOMINAL AORTA DURING NITROGEN MUSTARD THERAPY.
    HARRIES JR; BROWN F; BEECHER JL; OETTGEN HF
    Br Med J; 1963 Sep; 2(5360):783-6. PubMed ID: 14061325
    [No Abstract]   [Full Text] [Related]  

  • 35. THE DURATION OF THE MYELOTOXIC EFFECTS OF CIRCULATING ALKYLATING AGENTS.
    ULFOHN A; KRAMER SP; DORFMAN H; WITTEN B; WILLIAMSON C; SASS S; MILLER JI; SELIGMAN AM
    Cancer Res; 1964 Oct; 24():1659-65. PubMed ID: 14234010
    [No Abstract]   [Full Text] [Related]  

  • 36. [PELVIC REGIONAL PERFUSION IN ADVANCED GENITAL CANCER].
    LAGRUTTA J; CREGO H; GRINFELD D; FLORES E
    Sem Med; 1963 Jul; 123():282-6. PubMed ID: 14091097
    [No Abstract]   [Full Text] [Related]  

  • 37. A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.
    BRUNNER KW; YOUNG CW
    Ann Intern Med; 1965 Jul; 63():69-86. PubMed ID: 14305970
    [No Abstract]   [Full Text] [Related]  

  • 38. LYMPHATIC CANNULATION OF THE HEAD AND NECK.
    SMITH JR
    Plast Reconstr Surg; 1963 Dec; 32():607-19. PubMed ID: 14103015
    [No Abstract]   [Full Text] [Related]  

  • 39. CLINICAL EXPERIENCE OF CHEMOTHERAPY. A STUDY OF 100 CASES OF ADVANCED HEAD AND NECK CANCER.
    HARRISON DF
    Arch Otolaryngol; 1965 Feb; 81():175-82. PubMed ID: 14233934
    [No Abstract]   [Full Text] [Related]  

  • 40. SUSCEPTIBILITY OF INJURED TISSUES TO HEMATOGENOUS METASTASES: AN EXPERIMENTAL STUDY.
    ALEXANDER JW; ALTEMEIER WA
    Ann Surg; 1964 Jun; 159(6):933-44. PubMed ID: 14170294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.